Diagnosis and treatment of thyroid cancer in adult patients - Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych - Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022].

Autor: Jarząb B; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland. barbara.jarzab@io.gliwice.pl., Dedecjus M; Department of Oncological Endocrinology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Lewiński A; Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland.; Department of Endocrinology and Metabolic Diseases, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland., Adamczewski Z; Department of Nuclear Medicine, Medical University of Lodz, Poland, Poland., Bakuła-Zalewska E; Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland, Poland., Bałdys-Waligórska A; Andrzej Frycz Modrzewski Krakow University, Faculty of Medicine and Health Sciences, Department of Endocrinology and Internal Medicine, Poland., Barczyński M; Department of Endocrine Surgery, Third Chair of General Surgery, Jagiellonian University Medical College, Kraków, Poland., Biskup-Frużyńska M; Tumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland., Bobek-Billewicz B; Radiology and Diagnostic Imaging Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Bossowski A; Department of Paediatrics, Endocrinology, and Diabetology with a Cardiology Division, Medical University of Bialystok, Bialystok, Poland., Buziak-Bereza M; Chair and Department of Endocrinology, Jagiellonian University Medical College, Kraków, Cracow, Poland., Chmielik E; Tumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland., Czarniecka A; The Oncologic and Reconstructive Surgery Clinic, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland., Czepczyński R; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznań, Poland., Ćwikła J; Department of Cardiology and Internal Medicine; School of Medicine, University of Warmia and Mazury Olsztyn, Poland., Dobruch-Sobczak K; Department of Radiology II, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland, Warsaw, Poland., Dzięcioł J; Department of Human Anatomy, Medical University of Bialystok, Poland., Gawlik A; Department of Pediatrics and Pediatric Endocrinology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland., Gawrychowski J; Department of General and Endocrine Surgery, Medical University of Silesia, Katowice, Poland., Handkiewicz-Junak D; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Harasymczuk J; Department of Pediatric Surgery, Traumatology & Urology, Karol Marcinkowski University of Medical Sciences in Poznan, Karol Jonscher Teaching Hospital, Poland., Hubalewska-Dydejczyk A; Chair and Department of Endocrinology, Jagiellonian University Medical College, Kraków, Cracow, Poland., Januszkiewicz-Caulier J; Department of Oncological Endocrinology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Jarząb M; Breast Cancer Unit, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland., Kaczka K; Department of General and Oncological Surgery, Chair of Surgical Clinical Sciences, Medical University, Lodz, Lodz, Poland., Kalemba M; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Kamiński G; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine, Warsaw, Poland., Karbownik-Lewińska M; Chair and Department of Oncological Endocrinology, Medical University of Lodz, Lodz, Poland.; Department of Endocrinology and Metabolic Diseases, Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland., Kawecki A; Head and Neck Cancer Department, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Kluczewska-Gałka A; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Kolasińska-Ćwikła A; Department of Oncology and Radiotherapy, Maria Skłodowska‑Curie National Research Institute of Oncology, Warsaw, Poland., Kołton M; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Konturek A; Department of Endocrine Surgery, Third Chair of General Surgery, Jagiellonian University Medical College, Kraków, Poland., Kos-Kudła B; Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland., Kotecka-Blicharz A; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Kowalska A; Collegium Medicum Jan Kochanowski University Kielce, Poland, Poland.; Endocrinology Clinic, Holycross Cancer Center, Kielce, Poland., Krajewska J; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Kram A; Pathology Department, West Pomeranian Oncology Center, Szczecin, Poland., Królicki L; Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland., Kukulska A; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Kusiński M; Department of Endocrine, General and Vascular Surgery, Medical University of Lodz, Poland., Kuzdak K; Department of Endocrine, General and Vascular Surgery, Medical University of Lodz, Poland., Lange D; University of Technology, Faculty of Medicine, Katowice, Poland., Ledwon A; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Małecka-Tendera E; Department of Pediatrics and Pediatric Endocrinology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland., Mańkowski P; Department of Pediatric Surgery, Traumatology & Urology, Karol Marcinkowski University of Medical Sciences in Poznan, Karol Jonscher Teaching Hospital, Poland., Migda B; Diagnostic Ultrasound Lab, Department of Pediatric Radiology, Medical Faculty, Medical University of Warsaw, Poland., Niedziela M; Department of Oncology and Breast Diseases, CMKP, Warsaw, Poland., Oczko-Wojciechowska M; Department of Genetic and Molecular Diagnostics of Cancer, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland., Polnik D; Department of Pediatric Surgery and Organ Transplantation, The Children's Memorial Health Institute, Warsaw, Poland., Pomorski L; Department of General and Oncological Surgery, Chair of Surgical Clinical Sciences, Medical University, Lodz, Lodz, Poland., Ruchała M; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznań, Poland., Samborski K; Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland., Skowrońska-Szcześniak A; Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Poland., Stanek-Widera A; University of Technology, Faculty of Medicine, Katowice, Poland., Stobiecka E; Tumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland., Stojčev Z; Department of Oncology and Breast Diseases, CMKP, Warsaw, Poland., Suchorzepka-Simek M; Tumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland., Syrenicz A; Department of Endocrinology, Metabolic and Internal Diseases, Pomeranian Medical University, Szczecin, Poland., Szczepanek-Parulska E; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznań, Poland., Trofimiuk-Müldner M; Chair and Department of Endocrinology, Jagiellonian University Medical College, Kraków, Cracow, Poland., Tysarowski A; Cancer Molecular and Genetic Diagnostics Department, Maria Sklodowska‑Curie - National Research Institute of Oncology, Warsaw, Poland., Wygoda A; Radiation and Clinical Oncology Department, Maria Sklodowska‑Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland., Zajkowska K; Department of Oncological Endocrinology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Zembala-Nożyńska E; Tumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland., Żyłka A; Department of Oncological Endocrinology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Jazyk: angličtina
Zdroj: Endokrynologia Polska [Endokrynol Pol] 2022; Vol. 73 (2), pp. 173-300.
DOI: 10.5603/EP.a2022.0028
Abstrakt: The guidelines Thyroid Cancer 2022 are prepared based on previous Polish recommendations updated in 2018. They consider international guidelines - American Thyroid Association (ATA) 2015 and National Comprehensive Cancer Network (NCCN); however, they are adapted according to the ADAPTE process. The strength of the recommendations and the quality of the scientific evidence are assessed according to the GRADE system and the ATA 2015 and NCCN recommendations. The core of the changes made in the Polish recommendations is the inclusion of international guidelines and the results of those scientific studies that have already proven themselves prospectively. These extensions allow de-escalation of the therapeutic management in low-risk thyroid carcinoma, i.e., enabling active surveillance in papillary microcarcinoma to be chosen alternatively to minimally invasive techniques after agreeing on such management with the patient. Further extensions allow the use of thyroid lobectomy with the isthmus (hemithyroidectomy) in low-risk cancer up to 2 cm in diameter, modification of the indications for postoperative radioiodine treatment toward personalized approach, and clarification of the criteria used during postoperative L-thyroxine treatment. At the same time, the criteria for the preoperative differential diagnosis of nodular goiter in terms of ultrasonography and fine-needle aspiration biopsy have been clarified, and the rules for the histopathological examination of postoperative thyroid material have been updated. New, updated rules for monitoring patients after treatment are also presented. The updated recommendations focus on ensuring the best possible quality of life after thyroid cancer treatment while maintaining the good efficacy of this treatment.
Databáze: MEDLINE